New Report Looks at CIGS Photovoltaics

NanoMarkets, a leading industry analyst firm, today announced a new addition to its lineup of solar industry research reports. The new report, “Materials Markets for CIGS Photovoltaics” will be released in late January. Details about the report including a table of contents and preview are available at

About the Report:

CIGS offers some of the brightest hopes for the future of thin-film photovoltaics (TFPV) and also some of its greatest problems. Potentially, CIGS panels could provide the high conversion efficiencies of crystalline silicon with all the advantages of a thin-film material; flexibility, manufacturability and low weight. But CIGS is also a complex material whose characteristics are not yet well understood and it is clear that the road forward for CIGS PV as a whole will be driven by developments at the material level.

The major goal of this report is to analyze and quantify the opportunities that are emerging for materials suppliers and device manufacturers as the result of both established and emerging trends in development of CIGS materials. The report focuses on the core CIGS absorber materials, but also covers materials for electrodes, encapsulation, dielectrics, etc, since all of these materials are critical to the performance of CIGS PV. The report begins with a full review of the state of the art in CIGS materials and manufacturing, but its main focus is on business cases rather than technical issues. It includes strategic profiles of leading suppliers of materials into the CIGS space and of the materials-related activities of the emerging CIGS panel makers.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.